(Q86766611)

English

Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes

scientific article published on 25 March 2015

Statements

Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit